Appreciate everyones comments. Stimulated a discussion I never intended.
I agree; its unfortunate that the doctor isn't aware of the current approvals/supply situation, but for me there are several positives with that article:
Firstly I'm pleasantly surprised that a US based health professional is actually aware of Vitrogro;
Secondly she seems to have a fair understanding of the trials;
And thirdly she is making a pretty solid recommendation to her readership, in what in a few years time could potentially be TIS's biggest market.
Good luck all. Herro
TIS Price at posting:
37.0¢ Sentiment: Hold Disclosure: Held
